Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To demonstrate, in patients with tubercular or nontubercular mycobacterium infections with or
without HIV infection, the safety of thalidomide use as judged by symptoms, physical exam,
and studies of microbiologic, immunologic, hematologic, renal, and hepatic status. To
demonstrate efficacy of the drug as judged by status of fever, nutrition, tuberculosis
lesions, and immune responses.